Valentín Emilio Fernández-Elías

Dr. Valentín Emilio Fernández-Elías

Research Centre in Sport Sciences, Universidad Rey Juan Carlos, Madrid, Spain
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 September 2016 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Jesus Garcia-PallaresJesus Garcia-Pallares
Jesus Garcia-Pallares
Ricardo Morán-NavarroRicardo Morán-Navarro
Ricardo Morán-Navarro
JOJuan Fernando Ortega
Juan Fernando Ortega
Valentín Emilio Fernández-ElíasValentín Emilio Fernández-Elías
Valentín Emilio Fernández-Elías
RMRicardo Mora-Rodriguez
Ricardo Mora-Rodriguez
The purpose of this study was to determine, i) the reliability of blood lactate and ventilatory-based thresholds, ii) the lactate threshold that corresponds with each ventilatory threshold (VT1 and VT2) and with maximal lactate steady state test (MLSS) as a proxy of cycling performance. Fourteen aerobically-trained male cyclists ( 62.1±4.6 ml·kg-1·min-1) performed two graded exercise tests (50 W warm-up followed by 25 W·min-1) to exhaustion. Blood lactate, and data were collected at every stage. Workloads at VT1 (rise in ;) and VT2 (rise in ) were compared with workloads at lactate thresholds. Several continuous tests were needed to detect the MLSS workload. Agreement and differences among tests were assessed with ANOVA, ICC and Bland-Altman. Reliability of each test was evaluated using ICC, CV and Bland-Altman plots. Workloads at lactate threshold (LT) and LT+2.0 mMol·L-1 matched the ones for VT1 and VT2, respectively (p = 0.147 and 0.539; r = 0.72 and 0.80; Bias = -13.6 and 2.8, respectively). Furthermore, workload at LT+0.5 mMol·L-1 coincided with MLSS workload (p = 0.449; r = 0.78; Bias = -4.5). Lactate threshold tests had high reliability (CV = 3.4–3.7%; r = 0.85–0.89; Bias = -2.1–3.0) except for DMAX method (CV = 10.3%; r = 0.57; Bias = 15.4). Ventilatory thresholds show high reliability (CV = 1.6%–3.5%; r = 0.90–0.96; Bias = -1.8–2.9) except for RER = 1 and V-Slope (CV = 5.0–6.4%; r = 0.79; Bias = -5.6–12.4). Lactate threshold tests can be a valid and reliable alternative to ventilatory thresholds to identify the workloads at the transition from aerobic to anaerobic metabolism.

1 November 2013 in Medicine & Science in Sports & Exercise
Verified
Journal Article
Closed access
Jesus Garcia-PallaresJesus Garcia-Pallares
Jesus Garcia-Pallares
Valentín Emilio Fernández-ElíasValentín Emilio Fernández-Elías
Valentín Emilio Fernández-Elías
JOJuan F. Ortega
Juan F. Ortega
GMGloria Muñoz
Gloria Muñoz
JMJesús Muñoz-Guerra
Jesús Muñoz-Guerra
RMRicardo Mora-Rodriguez
Ricardo Mora-Rodriguez
The purpose of this study was to determine the oral dose of caffeine needed to increase muscle force and power output during all-out single multijoint movements. Thirteen resistance-trained men underwent a battery of muscle strength and power tests in a randomized, double-blind, crossover design, under four different conditions: (a) placebo ingestion (PLAC) or with caffeine ingestion at doses of (b) 3 mg · kg(-1) body weight (CAFF 3mg), (c) 6 mg · kg(-1) (CAFF 6mg), and (d) 9 mg · kg(-1) (CAFF 9mg). The muscle strength and power tests consisted in the measurement of bar displacement velocity and muscle power output during free-weight full-squat (SQ) and bench press (BP) exercises against four incremental loads (25%, 50%, 75%, and 90% one-repetition maximum [1RM]). Cycling peak power output was measured using a 4-s inertial load test. Caffeine side effects were evaluated at the end of each trial and 24 h later. Mean propulsive velocity at light loads (25%-50% 1RM) increased significantly above PLAC for all caffeine doses (5.4%-8.5%, P = 0.039-0.003). At the medium load (75% 1RM), CAFF 3mg did not improve SQ or BP muscle power or BP velocity. CAFF 9mg was needed to enhance BP velocity and SQ power at the heaviest load (90% 1RM) and cycling peak power output (6.8%-11.7%, P = 0.03-0.05). The CAFF 9mg trial drastically increased the frequency of the adverse side effects (15%-62%). The ergogenic dose of caffeine required to enhance neuromuscular performance during a single all-out contraction depends on the magnitude of load used. A dose of 3 mg · kg(-1) is enough to improve high-velocity muscle actions against low loads, whereas a higher caffeine dose (9 mg · kg(-1)) is necessary against high loads, despite the appearance of adverse side effects.

14 February 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
Juan Del CosoJuan Del Coso
Juan Del Coso
VMVíctor E Muñoz-Fernández
Víctor E Muñoz-Fernández
GMGloria Muñoz
Gloria Muñoz
Valentín Emilio Fernández-ElíasValentín Emilio Fernández-Elías
Valentín Emilio Fernández-Elías
JOJuan F Ortega
Juan F Ortega
JMJesús Muñoz-Guerra
Jesús Muñoz-Guerra
To investigate the effects of a caffeine-containing energy drink on soccer performance during a simulated game. A second purpose was to assess the post-exercise urine caffeine concentration derived from the energy drink intake. Nineteen semiprofessional soccer players ingested 630±52 mL of a commercially available energy drink (sugar-free Red Bull®) to provide 3 mg of caffeine per kg of body mass, or a decaffeinated control drink (0 mg/kg). After sixty minutes they performed a 15-s maximal jump test, a repeated sprint test (7×30 m; 30 s of active recovery) and played a simulated soccer game. Individual running distance and speed during the game were measured using global positioning satellite (GPS) devices. In comparison to the control drink, the ingestion of the energy drink increased mean jump height in the jump test (34.7±4.7 v 35.8±5.5 cm; P<0.05), mean running speed during the sprint test (25.6±2.1 v 26.3±1.8 km · h−1; P<0.05) and total distance covered at a speed higher than 13 km · h−1 during the game (1205±289 v 1436±326 m; P<0.05). In addition, the energy drink increased the number of sprints during the whole game (30±10 v 24±8; P<0.05). Post-exercise urine caffeine concentration was higher after the energy drink than after the control drink (4.1±1.0 v 0.1±0.1 µg · mL−1; P<0.05). A caffeine-containing energy drink in a dose equivalent to 3 mg/kg increased the ability to repeatedly sprint and the distance covered at high intensity during a simulated soccer game. In addition, the caffeinated energy drink increased jump height which may represent a meaningful improvement for headers or when players are competing for a ball.

1 May 2015 in Journal of Science and Medicine in Sport
Verified
Journal Article
Closed access
RMRicardo Mora-Rodriguez
Ricardo Mora-Rodriguez
Jesus Garcia-PallaresJesus Garcia-Pallares
Jesus Garcia-Pallares
JLJosé María López-Gullón
José María López-Gullón
Alvaro SamanesAlvaro Samanes
Alvaro Samanes
Valentín Emilio Fernández-ElíasValentín Emilio Fernández-Elías
Valentín Emilio Fernández-Elías
JOJuan F. Ortega
Juan F. Ortega

1 July 2014 in Nutrition, Metabolism and Cardiovascular Diseases
Verified
Journal Article
Closed access
RMRicardo Mora-Rodriguez
Ricardo Mora-Rodriguez
JOJ.F. Ortega
J.F. Ortega
NHN. Hamouti
N. Hamouti
Valentín Emilio Fernández-ElíasValentín Emilio Fernández-Elías
Valentín Emilio Fernández-Elías
JGJ. Cañete Garcia-Prieto
J. Cañete Garcia-Prieto
Vicente Martinez VizcainoVicente Martinez Vizcaino
Vicente Martinez Vizcaino

4 April 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
RMRicardo Mora-Rodriguez
Ricardo Mora-Rodriguez
Jesus Garcia-PallaresJesus Garcia-Pallares
Jesus Garcia-Pallares
Alvaro SamanesAlvaro Samanes
Alvaro Samanes
JOJuan Fernando Ortega
Juan Fernando Ortega
Valentín Emilio Fernández-ElíasValentín Emilio Fernández-Elías
Valentín Emilio Fernández-Elías
To investigate whether caffeine ingestion counteracts the morning reduction in neuromuscular performance associated with the circadian rhythm pattern. Twelve highly resistance-trained men underwent a battery of neuromuscular tests under three different conditions; i) morning (10:00 a.m.) with caffeine ingestion (i.e., 3 mg kg−1; AMCAFF trial); ii) morning (10:00 a.m.) with placebo ingestion (AMPLAC trial); and iii) afternoon (18:00 p.m.) with placebo ingestion (PMPLAC trial). A randomized, double-blind, crossover, placebo controlled experimental design was used, with all subjects serving as their own controls. The neuromuscular test battery consisted in the measurement of bar displacement velocity during free-weight full-squat (SQ) and bench press (BP) exercises against loads that elicit maximum strength (75% 1RM load) and muscle power adaptations (1 m s−1 load). Isometric maximum voluntary contraction (MVCLEG) and isometric electrically evoked strength of the right knee (EVOKLEG) were measured to identify caffeine's action mechanisms. Steroid hormone levels (serum testosterone, cortisol and growth hormone) were evaluated at the beginning of each trial (PRE). In addition, plasma norepinephrine (NE) and epinephrine were measured PRE and at the end of each trial following a standardized intense (85% 1RM) 6 repetitions bout of SQ (POST). In the PMPLAC trial, dynamic muscle strength and power output were significantly enhanced compared with AMPLAC treatment (3.0%–7.5%; p≤0.05). During AMCAFF trial, muscle strength and power output increased above AMPLAC levels (4.6%–5.7%; p≤0.05) except for BP velocity with 1 m s−1 load (p = 0.06). During AMCAFF, EVOKLEG and NE (a surrogate of maximal muscle sympathetic nerve activation) were increased above AMPLAC trial (14.6% and 96.8% respectively; p≤0.05). These results indicate that caffeine ingestion reverses the morning neuromuscular declines in highly resistance-trained men, raising performance to the levels of the afternoon trial. Our electrical stimulation data, along with the NE values, suggest that caffeine increases neuromuscular performance having a direct effect in the muscle.